| References |
Top |
| REF 1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6624).
|
| REF 2 |
ClinicalTrials.gov (NCT02229981) An Early-Phase Clinical Trial Evaluating ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma. U.S. National Institutes of Health.
|
| REF 3 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| REF 4 |
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013 Sep;12(9):688-702.
|
| REF 5 |
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.J Exp Clin Cancer Res.2015 Sep 4;34:94.
|
| REF 6 |
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.Cell Signal.2013 Apr;25(4):1011-7.
|
